Literature DB >> 16426233

Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.

Valeska Vollrath1, Ana M Wielandt, Mirentxu Iruretagoyena, Jose Chianale.   

Abstract

The Nrf2 (nuclear factor-erythroid 2 p45-related factor 2) transcription factor regulates gene expression of the GCLC (glutamate-cysteine ligase catalytic subunit), which is a key enzyme in glutathione synthesis, and GSTs (glutathione S-transferases) via the ARE (antioxidant-response element). The Mrp2 (multidrug-resistance protein 2) pump mediates the excretion of GSH and GSSG excretion as well as endo- and xeno-biotics that are conjugated with GSH, glucuronate or sulphate. Considering that Mrp2 acts synergistically with these enzymes, we hypothesized that the regulation of Mrp2 gene expression is also dependent on Nrf2. Using BHA (butylated hydroxyanisole), which is a classical activator of the ARE-Nrf2 pathway, we observed an increase in the transcriptional activity of Mrp2, GCLC and Gsta1/Gsta2 genes in the mouse liver. A similar pattern of co-induction of Mrp2 and GCLC genes was also observed in mouse (Hepa 1-6) and human (HepG2) hepatoma cells treated with BHA, beta-NF (beta-naphthoflavone), 2,4,5-T (trichlorophenoxyacetic acid) or 2AAF (2-acetylaminofluorene), suggesting that these genes share common mechanism(s) of transcriptional activation in response to exposure to xenobiotics. To define the mechanism of Mrp2 gene induction, the 5'-flanking region of the mouse Mrp2 gene (2.0 kb) was isolated, and two ARE-like sequences were found: ARE-2 (-1391 to -1381) and ARE-1 (-95 to -85). Deletion analyses demonstrated that the proximal region (-185 to +99) contains the elements for the basal expression and xenobiotic-mediated induction of the Mrp2 gene. Gel-shift and supershift assays indicated that Nrf2-protein complexes bind ARE sequences of the Mrp2 promoter, preferentially to the ARE-1 sequence. Overexpression of Nrf2 increased ARE-1-mediated CAT (chloramphenicol acetyltransferase) gene activity, while overexpression of mutant Nrf2 protein repressed the activity. Thus Nrf2 appears to regulate Mrp2 gene expression via an ARE element located at the proximal region of its promoter in response to exposure to xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426233      PMCID: PMC1462684          DOI: 10.1042/BJ20051518

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  The human multidrug resistance protein 2 gene: functional characterization of the 5'-flanking region and expression in hepatic cells.

Authors:  T Tanaka; T Uchiumi; E Hinoshita; A Inokuchi; S Toh; M Wada; H Takano; K Kohno; M Kuwano
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

2.  Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites.

Authors:  H M Kauffmann; B Vorderstemann; D Schrenk
Journal:  Toxicology       Date:  2001-10-05       Impact factor: 4.221

3.  Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane.

Authors:  L Payen; A Courtois; M Loewert; A Guillouzo; O Fardel
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

4.  The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin.

Authors:  J D Hayes; S A Chanas; C J Henderson; M McMahon; C Sun; G J Moffat; C R Wolf; M Yamamoto
Journal:  Biochem Soc Trans       Date:  2000-02       Impact factor: 5.407

5.  Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.

Authors:  B Stöckel; J König; A T Nies; Y Cui; M Brom; D Keppler
Journal:  Eur J Biochem       Date:  2000-03

Review 6.  Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2.

Authors:  Viviana A Catania; Enrique J Sánchez Pozzi; Marcelo G Luquita; María L Ruiz; Silvina S M Villanueva; Brett Jones; Aldo D Mottino
Journal:  Ann Hepatol       Date:  2004 Jan-Mar       Impact factor: 2.400

Review 7.  Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors.

Authors:  Paul Nioi; John D Hayes
Journal:  Mutat Res       Date:  2004-11-02       Impact factor: 2.433

8.  Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line.

Authors:  Takahisa Tarumoto; Tadashi Nagai; Ken Ohmine; Takuji Miyoshi; Makiko Nakamura; Takahito Kondo; Kenji Mitsugi; Syuji Nakano; Kazuo Muroi; Norio Komatsu; Keiya Ozawa
Journal:  Exp Hematol       Date:  2004-04       Impact factor: 3.084

9.  Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice.

Authors:  Jiang Li; Thor D Stein; Jeffrey A Johnson
Journal:  Physiol Genomics       Date:  2004-08-11       Impact factor: 3.107

Review 10.  The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.

Authors:  Lauretta M S Chan; Simon Lowes; Barry H Hirst
Journal:  Eur J Pharm Sci       Date:  2004-01       Impact factor: 4.384

View more
  78 in total

1.  Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress.

Authors:  Luis E Gomez-Quiroz; Daekwan Seo; Yun-Han Lee; Mitsuteru Kitade; Timo Gaiser; Matthew Gillen; Seung-Bum Lee; Ma Concepcion Gutierrez-Ruiz; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson; Jens U Marquardt
Journal:  Toxicology       Date:  2016-07-06       Impact factor: 4.221

2.  Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.

Authors:  Suryakant K Niture; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression.

Authors:  Ludovic Martin; Vanessa Douet; Christopher M VanWart; Matthew B Heller; Olivier Le Saux
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Reactive oxygen species in cancer stem cells.

Authors:  Xiaoke Shi; Yan Zhang; Junheng Zheng; Jingxuan Pan
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

5.  Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.

Authors:  Shailendra Kumar Dhar Dwivedi; Nidhi Singh; Rashmi Kumari; Jay Sharan Mishra; Sarita Tripathi; Priyam Banerjee; Priyanka Shah; Vandana Kukshal; Abdul Malik Tyagi; Anil Nilkanth Gaikwad; Rajnish Kumar Chaturvedi; Durga Prasad Mishra; Arun Kumar Trivedi; Somali Sanyal; Naibedya Chattopadhyay; Ravishankar Ramachandran; Mohammad Imran Siddiqi; Arun Bandyopadhyay; Ashish Arora; Thomas Lundåsen; Sayee Priyadarshini Anakk; David D Moore; Sabyasachi Sanyal
Journal:  Mol Endocrinol       Date:  2011-04-14

Review 6.  Nrf2:INrf2 (Keap1) signaling in oxidative stress.

Authors:  James W Kaspar; Suryakant K Niture; Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2009-08-07       Impact factor: 7.376

Review 7.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

Review 8.  Regulation of Nrf2-an update.

Authors:  Suryakant K Niture; Raju Khatri; Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2013-02-19       Impact factor: 7.376

9.  ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.

Authors:  Yuji Tanaka; Lauren M Aleksunes; Yue Julia Cui; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-01-29       Impact factor: 4.849

10.  RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.

Authors:  Anju Singh; Swetlana Boldin-Adamsky; Rajesh K Thimmulappa; Srikanta K Rath; Hagit Ashush; Jonathan Coulter; Amanda Blackford; Steven N Goodman; Fred Bunz; Walter H Watson; Edward Gabrielson; Elena Feinstein; Shyam Biswal
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.